Logo Image

Authors

Elizabeth Gardner
Latest Article

Older Breast Cancer Patients Require Special Consideration

Treating older patients with breast cancer must include more quality of life considerations and different types of survival calculations.

Elizabeth Leick
Latest Article

Expert Discusses Value of Venetoclax After BCR Inhibition in CLL

Jeffrey Jones, MD, discusses promising early data for venetoclax in chronic lymphocytic leukemia after progression on BCR-pathway inhibitors, as well as the next steps with the research.

Elizabeth Mittendorf Dana-Farber
Elizabeth R. Plimack, MD, Fox Chase Cancer Center
Elizabeth Whittington
Latest Article

Long-term Aspirin Use Decreases Risk of GI Cancers, Especially Colorectal

A recent study joins a body of evidence suggesting that long-term, regular aspirin use is associated with a reduced risk for cancer, with the most dramatic reduction being seen in colorectal cancer incidence.

Ellen K. Ritchie, MD, New York Presbyterian Hospital
Ellen K. Ritchie, MD, Weill Cornell Medicine
Ellie Leick
Latest Article

Navigating COVID-19 Challenges to Provide Optimal Cancer Care

Gilberto De Lima Lopes, MD, discusses the impact of COVID-19 on his practice and how he is coping with the changes caused by the pandemic.

Emad Kandil, MD, FACS, FACE
Latest Article

Robotic Surgery Represents a Notable Advance in Thyroid Cancer Care

Amid a rising incidence of thyroid cancer, endocrine surgeons have increasingly explored minimally invasive approaches for operating on patients with the disease.

Emily A. Barber, BS
Latest Article

Best Initial Treatment Strategies for EGFR-Mutant Lung Cancer

This review will focus on current therapies used in the first-line setting for advanced EGFR mutation positive non–small cell lung cancer (NSCLC) followed by emerging data that may lead to a transition in the choice for initial therapy in these patients.

Emily Brill
Latest Article

From "Least Engaged" to "Most Happy": 4 Types of OCM Participant

The goal of the Oncology Care Model is to incentivize high-quality, coordinated care with an episode-based payment model that emphasizes patient access and navigation.

Emma Hitt, PhD
Latest Article

Novel Agents Revolutionize Melanoma Treatment

Until recently, the cornerstone of therapy for metastatic melanoma had been chemotherapy with dacarbazine (DTIC) and immunotherapy with high-dose interleukin-2 (HD IL-2) or interferon-α (IFN-α).

Emma S. C. Carr, BSc, MSc, PhD
Latest Article

Rituximab for Chronic Lymphocytic Leukemia in Treatment-Naïve and Treatment-Experienced Patients

A mixed treatment comparison demonstrated that FCR significantly prolonged PFS compared with all other treatments and significantly increased ORR compared with all other treatments.

Emmanuel S. Antonarakis, MBBCh, Johns Hopkins Medicine
Enriqueta Felip, MD, PhD, Vall d’Hebron University Hospital
Er Chen, MPP
Latest Article

Cost-Effectiveness of 70-Gene MammaPrint Signature in Node-Negative Breast Cancer

Breast cancers with similar clinicopathologic characteristics may have strikingly different outcomes.

Eric B. Durbin, DrPH, MS
Latest Article

Kentucky Taps Into Data Repositories for an Attack on its Extraordinary Cancer Burden

Open access to unbiased data repositories of molecular and clinical data will be essential to accelerating future discoveries in precision medicine.

Eric H. Liu, MD, FACS, Rocky Mountain Cancer Center
Eric J. Sherman, MD, Memorial Sloan Kettering Cancer Center
Eric J. Sherman, MD, MSKCC
Eric Jonasch, MD, MD Ande
Eric Jonasch, MD, MD Anders
Eric Liu, MD, FACS, Rocky Mountain Cancer Centers
Eric Roeland, MD, UC San Diego Health
Eric Roeland, MD, University of California, San Diego
Eric Van Cutsem, MD, PhD, University of Leuven
Eric Wisotzky, MD
Latest Article

Rehabilitation Should Be Part of Cancer Treatment

Rehabilitation is medical care that cancer patients should expect and that it should be delivered by trained rehabilitation professionals: physiatrists, physical therapists, occupational therapists, or speech language pathologists.

Erica DiNapoli, OncLive
Erica DiNapoli

Erica DiNapoli is an Assistant Editor for OncLive®. She joined the company in 2020 and now assists in editing and publishing both videos and informational articles to the website; she also helps manage the social media platforms. Prior to joining MJH Life Sciences, she was a student at Monmouth University and held two marketing internships at United Teletech Financial Federal Credit Union and Trendsetter Media & Marketing.

Latest Article

Chasing Survival Benefit With Novel Systemic Strategies in Early-Stage NSCLC

Kaushal Parikh, MD, MBBS, highlights ongoing research exploring systemic approaches in early-stage non¬–small cell lung cancer and shares where future efforts are headed.

Erika N. Brown, BS, MS, PharmD
Latest Article

Triple Receptor-Negative Breast Cancer: Current and Future Treatments

Breast cancer is the number one malignancy diagnosed in women in the United States. In 2009, it was estimated that more than 190,000 individuals would be diagnosed with breast cancer and approximately 40,000 would die from the disease.

Erin A. Gillaspie, MD, MPH
Latest Article

Neoadjuvant Immunotherapy May Change Standard of Care in Early-Stage NSCLC

Wade T. Iams, MD, and Erin A. Gillaspie, MD, MPH, discuss the impact that immunotherapy has had on the treatment of patients with early-stage non–small cell lung cancer.